Clover Health Investments, Corp.

NasdaqGS:CLOV Stock Report

Mkt Cap: US$616.5m

Clover Health Investments Future Growth

How is Clover Health Investments forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


42.6%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGS:CLOV - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20252,880-91N/AN/A2
12/31/20242,470-163-103-1025
12/31/20232,173-242-124-1236
9/30/20223,041-442-76-75N/A
6/30/20222,564-401-222-222N/A
3/31/20222,075-615-247-246N/A
12/31/20211,361-588-283-282N/A
9/30/20211,158-527-263-262N/A
6/30/2021922-487-252-252N/A
3/31/2021721-160-175-174N/A
12/31/2020690-136-119-118N/A
9/30/2020624-89-126-126N/A
6/30/2020572-145-116-116N/A
3/31/2020507-272-163-163N/A
12/31/2019455-364-160-160N/A
12/31/2018281-202-155-153N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CLOV is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: CLOV is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: CLOV is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: CLOV's revenue is expected to decline over the next 3 years (-3.8% per year).

High Growth Revenue: CLOV's revenue is forecast to decline over the next 3 years (-3.8% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CLOV is forecast to be unprofitable in 3 years.


Discover growth companies